ANI PHARMACEUTICALS INC (ANIP) › Operating Cash FlowANI PHARMACEUTICALS INC (ANIP) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2012: -$137.0K2013: -$5.48M2014: $22.03M2015: $17.26M2016: $27.47M2017: $39.42M2018: $67.07M2019: $45.63M2020: $15.27M2021: $3.32M2022: -$31.20M2023: $118.96M2024: $64.02M2025: $185.22M$185.22M2012Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$185.22M+189.3%2024$64.02M-46.2%2023$118.96M+481.2%2022-$31.20M-1039.3%2021$3.32M-78.2%2020$15.27M-66.5%2019$45.63M-32.0%2018$67.07M+70.2%2017$39.42M+43.5%2016$27.47M+59.1%2015$17.26M-21.6%2014$22.03M+501.8%2013-$5.48M-3902.9%2012-$137.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share